PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial–Mesenchymal Transition
Top Cited Papers
- 13 December 2018
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 24 (24), 6319-6330
- https://doi.org/10.1158/1078-0432.ccr-18-1270
Abstract
Purpose: Circular RNAs (circRNAs), a novel class of non-coding RNAs, have recently been drawn lots of attention in the pathogenesis of human cancers. However, the role of circRNAs in cancer cells epithelial-mesenchymal transition (EMT) remains unclear. In this study, we aimed to identify novel circRNAs that regulates urothelial carcinoma of the bladder (UCB) cells EMT and explored their regulatory mechanisms and clinical significance in UCBs. Experimental Design: We first screened circRNA expression profiles using a circRNA microarray in paired UCB and normal tissues, and then studied the clinical significance of an up-regulated circRNA, circPRMT5, in a large cohort of UCB patients. We further investigated the functions and underlying mechanisms of circPRMT5 in UCB cells EMT. Moreover, we evaluated the regulation effect of circPRMT5 on miR-30c, and its targets genes SNAIL1 and E-cadherin, in two independent cohorts from our institute and the Cancer Genome Atlas (TCGA). Results: We demonstrated that upregulated expression of circPRMT5 was positively associated with advanced clinical stage and worse survival in UCB patients. We further revealed that circPRMT5 promoted UCB cell EMT via sponging miR-30c. Clinical analysis from two independent UCB cohorts showed that the circPRMT5/miR-30c/SNAIL1/E-cadherin pathway was essential in supporting UCBs progression. Importantly, we identified that circPRMT5 was up-regulated in serum and urine exosomes from UCB patients, and significantly correlated with tumor metastasis. Conclusions: CircPRMT5 exerts critical roles in promoting UCB cells EMT and/or aggressiveness and is a prognostic biomarker of the disease, suggesting that circPRMT5 may serve as an exploitable therapeutic target for UCB patients.Keywords
Other Versions
Funding Information
- National Key R&D Program of China (2017YFC1309001, 2016YFC1302305)
- National Natural Science Foundation of China (81602233)
- National Natural Science Foundation of China (81672530)
- National Natural Science Foundation of China (81772726)
- National Natural Science Foundation of China (81730072)
- Natural Science Foundation of Guangdong Province (2016A030310219)
This publication has 37 references indexed in Scilit:
- Bioactive Exosomes: Possibilities for Diagnosis and Management of Bladder CancerJournal of Urology, 2014
- Circular RNA and miR-7 in CancerCancer Research, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Circular RNAs are abundant, conserved, and associated with ALU repeatsRNA, 2012
- Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironmentsSeminars in Immunopathology, 2011
- Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sitesGenome Biology, 2010
- miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor TherapyClinical Cancer Research, 2009
- Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription FactorMolecular and Cellular Biology, 2008
- Circular transcripts of the testis-determining gene Sry in adult mouse testisCell, 1993
- Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes.The Journal of cell biology, 1985